An Interesting Observation of PDA Closure with Oral Paracetamol in Preterm Neonates
- PMID: 24027742
- PMCID: PMC3761951
- DOI: 10.4103/2249-4847.109245
An Interesting Observation of PDA Closure with Oral Paracetamol in Preterm Neonates
Abstract
Patent ductus arteriosus (PDA), in which there is a persistent communication between the descending thoracic aorta and the pulmonary artery that results from failure of normal physiologic closure of the fetal ductus, is one of the more common congenital heart defects in preterm neonates. The closure of PDA can be done with either Indomethacin or Brufen which are cyclooxygenase 1, 2 inhibitor; however these drugs are associated with side effects. We report an interesting findings of ductal closure in 10 preterm neonates (gestational age 27-33 wks) presenting with significant large PDA who had failed or had absolute contraindication with Brufen. These preterm neonates were treated with oral paracetamol in the dose of 15 mg/kg 8 hourly. The PDA closure was achieved within 48 h and there was no complication.
Keywords: Ductus; brufen; paracetamol; preterm.
Conflict of interest statement
References
-
- Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: A surprising new approach to patent ductus arteriosus treatment. Pediatrics. 2011;128:e1618–21. - PubMed
-
- Sekar KC, Corff KE. Treatment of patent ductus arteriosus: Indomethacin or ibuprofen? J Perinatol. 2008;28:S60–2. - PubMed
-
- Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2006;1:CD004213. - PubMed
-
- Jones LJ, Craven PD, Attia J, Thakkinstian A, Wright I. Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2011;96:F45–52. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources